Results of a Randomized, Placebo-Controlled, Phase 3 Trial of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty (PAINWeek 2025) - Jul 28, 2025 - Abstract #P-044; Pres time: Sep 4, 2025; 04:00 PM - 05:30 PM; Location: Exhibit Hall (Level 4); "Rescue medications included IV morphine for the first 24 hours following study drug administration followed by oral oxycodone thereafter. A total of 300 subjects were included in the study (400µg/400µg: n=101; 400µg/200µg: n=98; placebo: n=101). Subjects were predominantly female (98.7%) ranging in age from 22 to 68 years. Baseline characteristics were generally comparable between groups."
Clinical • P3 data • Addiction (Opioid and Alcohol) • CNS Disorders • Depression • Pain • Psychiatry
|
|
Neil Singla, MD; Harold Minkowitz, MD; Ben J. Vaughn, MS; Joseph C. Grieco, PhD; Marc Lesnick, PhD; James Hackworth, PhD
|